Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...
One of the key advantages of premium cataract surgery at ClearSight is the use of advanced intraocular lenses (IOLs) that cater to a wide range of vision correction needs. Multifocal IOLs, for example ...